Home · Solutions
PANCRA by Sycai
The world’s first MDR-approved AI-solution to improve diagnosis of pancreatic lesions
AI solution that improves the diagnosis and follow-up of pancreatic lesions on CT scans. Detects pre-cancerous cysts and malignancies, with and without contrast.
Proven performance in pancreatic leasion detection
Works across scanner vendors and acquisition protocols.
Sensitivity of Detection
96.6 %
Standard of care surpassed
Specificity on Detection
88.3 %
High precision, low false positives
False Negative Rate
3.8 %
In detection
Incidenctal Radiological Findings
3 x
Higher detection vs. clinical practice
How PANCRA™ works
Solution Features
Opportunistic detection of findings
Automates the identification of known or incidental lesions, with no manual trigger, flagging findings on any abdominal CT scan regardless of the reason it was ordered. With and without contrast.
Characterization of lesions
Provides detailed lesion 2D & 3D measurements and precise anatomical location, structured and ready to include in the radiological report.
Automatic longitudinal analysis
Sycai Medical holds the only patent enabling automatic single-lesion tracking over time across multiple patient studies, ensuring standardized, consistent follow-up with no manual intervention.
Fully integrable in current workflow
PANCRA™ is CE-Marked and ready to deploy
Clinically certified under EU MDR (Regulation 2017/745) and backed by ISO 13485 quality management. PANCRA™ is a market-ready medical device software, approved for use in adult patients.